R&D

Our R&D projects include:

1. In vitro cell-based technologies as alternative for animal testing

Drug and chemical screening

Toxicity studies

Biocompatibility of biomaterial

 2. Cell therapy technologies for treating human diseases

Therapeutic cancer vaccine technology platforms. We are actively seeking partners in the pharmaceutical industry and clinical centres in order to co-develop our patented gene-modified dendritic cell therapy for the treatment of human cancer.

Muscle stem cell therapy for Muscular Dystrophy, FP7-HESUB